ACETAMINOPHEN 80 MG

ACETAMINOPHEN 80 MG was reported 91 times

ACETAMINOPHEN 80 MG is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MUSCLE RELAXANT DRUG LEVEL ABOVE THERAPEUTIC 1 0.1250
1 BASILAR ARTERY ANEURYSM 1 0.0303
2 VERTEBRAL ARTERY STENOSIS 1 0.0065
3 NECROTISING SOFT TISSUE INFECTION 1 0.0043
4 GENITAL BLISTER 1 0.0036
5 BLOOD CREATINE PHOSPHOKINASE DECREASED 1 0.0030
6 CEREBRAL ARTERY STENOSIS 1 0.0020
7 INCORRECT DRUG DOSAGE FORM ADMINISTERED 1 0.0016
8 LABORATORY TEST INTERFERENCE 1 0.0013
9 ARTERIOVENOUS MALFORMATION 1 0.0011
10 RECTAL ULCER 1 0.0009
11 ACUTE LUNG INJURY 1 0.0008
12 PHYSICAL PRODUCT LABEL ISSUE 1 0.0008
13 CARDIOVERSION 1 0.0007
14 PRERENAL FAILURE 1 0.0007
15 INTELLECTUAL DISABILITY 1 0.0007
16 RECALLED PRODUCT 1 0.0006
17 OCCULT BLOOD POSITIVE 1 0.0005
18 CAPILLARY LEAK SYNDROME 1 0.0005
19 RETROPERITONEAL HAEMATOMA 1 0.0005
20 OXYGEN SATURATION ABNORMAL 1 0.0004
21 PHARYNGEAL DISORDER 1 0.0003
22 STUPOR 1 0.0003
23 REFUSAL OF TREATMENT BY PATIENT 2 0.0003
24 GASTRIC INFECTION 1 0.0003
25 CREATININE RENAL CLEARANCE DECREASED 1 0.0002
26 INTERNATIONAL NORMALISED RATIO DECREASED 1 0.0002
27 LIVER FUNCTION TEST INCREASED 5 0.0002
28 HAEMOLYTIC ANAEMIA 2 0.0002
29 ORGANISING PNEUMONIA 1 0.0002
30 SERUM FERRITIN INCREASED 1 0.0002
31 BRUXISM 1 0.0002
32 SOCIAL AVOIDANT BEHAVIOUR 1 0.0002
33 PRODUCT LABEL CONFUSION 1 0.0002
34 INFUSION RELATED REACTION 11 0.0002
35 OLIGURIA 1 0.0002
36 INFUSION SITE EXTRAVASATION 1 0.0002
37 INFUSION SITE SWELLING 1 0.0002
38 ECCHYMOSIS 1 0.0001
39 DROOLING 1 0.0001
40 MENTAL STATUS CHANGES 4 0.0001
41 HYPOALBUMINAEMIA 1 0.0001
42 TORSADE DE POINTES 1 0.0001
43 ATRIAL FLUTTER 1 0.0001
44 UNRESPONSIVE TO STIMULI 3 0.0001
45 RECALLED PRODUCT ADMINISTERED 1 0.0001
46 VENTRICULAR EXTRASYSTOLES 1 0.0001
47 ASPARTATE AMINOTRANSFERASE INCREASED 5 0.0001
48 MELAENA 2 0.0001
49 TRANSAMINASES INCREASED 2 0.0001
50 STATUS EPILEPTICUS 1 0.0001
51 MUSCLE RIGIDITY 1 0.0001
52 ALANINE AMINOTRANSFERASE INCREASED 5 0.0001
53 TENDON RUPTURE 1 0.0001
54 INFUSION SITE PAIN 1 0.0001
55 ORAL DISCOMFORT 1 0.0001
56 HYPOMAGNESAEMIA 1 0.0001
57 SUBDURAL HAEMATOMA 1 0.0001
58 HAEMORRHAGE INTRACRANIAL 1 0.0001
59 DRUG DISPENSING ERROR 1 0.0001
60 VENTRICULAR TACHYCARDIA 1 0.0001
61 CHILLS 7 0.0001
62 HYPOXIA 2 0.0001
63 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
64 POST PROCEDURAL COMPLICATION 1 0.0001
65 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
66 BODY TEMPERATURE INCREASED 1 0.0000
67 INJECTION SITE WARMTH 1 0.0000
68 RECTAL HAEMORRHAGE 2 0.0000
69 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
70 HEPATIC ENZYME INCREASED 3 0.0000
71 SHOCK 1 0.0000
72 THERAPY INTERRUPTED 3 0.0000
73 BLOOD PRESSURE FLUCTUATION 1 0.0000
74 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
75 HYPOPHAGIA 1 0.0000
76 THERAPY CESSATION 2 0.0000
77 RASH GENERALISED 1 0.0000
78 HAEMATOMA 1 0.0000
79 FEELING COLD 1 0.0000
80 DEMENTIA 1 0.0000
81 URINARY INCONTINENCE 1 0.0000
82 DRUG-INDUCED LIVER INJURY 1 0.0000
83 HEAD INJURY 1 0.0000
84 BLOOD CREATININE INCREASED 2 0.0000
85 IMPAIRED HEALING 1 0.0000
86 BLOOD PRESSURE DECREASED 2 0.0000
87 HAEMOGLOBIN DECREASED 3 0.0000
88 HEART RATE DECREASED 1 0.0000
89 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
90 C-REACTIVE PROTEIN INCREASED 1 0.0000
91 RESTLESSNESS 1 0.0000
92 HEPATIC FUNCTION ABNORMAL 1 0.0000
93 COLITIS 1 0.0000
94 ABNORMAL BEHAVIOUR 1 0.0000
95 RHABDOMYOLYSIS 1 0.0000
96 HYPERHIDROSIS 3 0.0000
97 MUSCULOSKELETAL STIFFNESS 2 0.0000
98 TACHYCARDIA 2 0.0000
99 COLITIS ULCERATIVE 1 0.0000
100 ADVERSE DRUG REACTION 2 0.0000
101 HYPOGLYCAEMIA 1 0.0000
102 SYNCOPE 2 0.0000
103 CHEST DISCOMFORT 2 0.0000
104 SPEECH DISORDER 1 0.0000
105 CONFUSIONAL STATE 3 0.0000
106 OEDEMA 1 0.0000
107 HAEMATOCHEZIA 1 0.0000
108 TREMOR 3 0.0000
109 BLISTER 1 0.0000
110 OXYGEN SATURATION DECREASED 1 0.0000
111 STOMATITIS 1 0.0000
112 DEEP VEIN THROMBOSIS 1 0.0000
113 INJECTION SITE PRURITUS 1 0.0000
114 ABDOMINAL PAIN UPPER 3 0.0000
115 VISION BLURRED 2 0.0000
116 INJECTION SITE REACTION 1 0.0000
117 BURNING SENSATION 1 0.0000
118 BRONCHITIS 1 0.0000
119 ACUTE KIDNEY INJURY 2 0.0000
120 PRURITUS 5 0.0000
121 VOMITING 6 0.0000
122 DYSPNOEA 7 0.0000
123 CARDIAC ARREST 1 0.0000
124 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
125 CHEST PAIN 2 0.0000
126 HYPERSENSITIVITY 2 0.0000
127 MIGRAINE 1 0.0000
128 CONTUSION 1 0.0000
129 ATRIAL FIBRILLATION 1 0.0000
130 DIZZINESS 5 0.0000
131 FLUSHING 1 0.0000
132 SINUSITIS 1 0.0000
133 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
134 CONSTIPATION 2 0.0000
135 FALL 3 0.0000
136 NAUSEA 7 0.0000
137 MUSCULAR WEAKNESS 1 0.0000
138 PYREXIA 3 0.0000
139 SEIZURE 1 0.0000
140 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
141 ABDOMINAL PAIN 2 0.0000
142 PALPITATIONS 1 0.0000
143 INJECTION SITE ERYTHEMA 1 0.0000
144 LOSS OF CONSCIOUSNESS 1 0.0000
145 PRODUCT QUALITY ISSUE 1 0.0000
146 COUGH 2 0.0000
147 PAIN IN EXTREMITY 2 0.0000
148 BLOOD PRESSURE INCREASED 1 0.0000
149 PARAESTHESIA 1 0.0000
150 URTICARIA 1 0.0000
151 TOXICITY TO VARIOUS AGENTS 1 0.0000
152 URINARY TRACT INFECTION 1 0.0000
153 COVID-19 1 0.0000
154 NO ADVERSE EVENT 1 0.0000
155 MUSCLE SPASMS 1 0.0000
156 ASTHENIA 2 0.0000
157 BLOOD GLUCOSE INCREASED 1 0.0000
158 GAIT DISTURBANCE 1 0.0000
159 HYPOTENSION 1 0.0000
160 PAIN 3 0.0000
161 HEADACHE 3 0.0000
162 HYPERTENSION 1 0.0000
163 OVERDOSE 1 0.0000
164 RASH 2 0.0000
165 WEIGHT INCREASED 1 0.0000
166 BACK PAIN 1 0.0000
167 FEELING ABNORMAL 1 0.0000
168 INSOMNIA 1 0.0000
169 WEIGHT DECREASED 1 0.0000
170 INJECTION SITE PAIN 1 0.0000
171 DIARRHOEA 2 0.0000
172 PNEUMONIA 1 0.0000
173 MALAISE 1 0.0000
174 DRUG INEFFECTIVE 3 0.0000
175 FATIGUE 1 0.0000
176 OFF LABEL USE 1 0.0000